Terguride—a new dopamine agonist drug: a comparison of its neuroendocrine and side effect profile with bromocriptine**Supported in part by a grant from Schering Ltd., Berlin, German Federal Republic.-Reference-Cited by-同舟云学术

Terguride—a new dopamine agonist drug: a comparison of its neuroendocrine and side effect profile with bromocriptine**Supported in part by a grant from Schering Ltd., Berlin, German Federal Republic.

Published:1988-04 Issue:4 Volume:49 Page:589-594
ISSN:0015-0282
Container-title:Fertility and Sterility
language:en
Short-container-title:Fertility and Sterility

Author:

Ciccarelli Enrica,Touzel Richard,Besser Michael,Grossman Ashley

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Reproductive Medicine

Reference15 articles.

1. Regular review: prolactinomas;Grossman;Br Med J,1985

2. Bromocriptine;Vance;Ann Intern Med,1984

3. Size reduction of macroprolactinomas by bromocriptine or lisuride treatment;Chiodini;J Clin Endocrinol Metab,1981

4. Clinical evaluation of lysuride in the management of hyperprolactinemia;Bouloux;Br Med J,1987

5. Neuroendocrine effects of lisuride and its 9, 10 dihydrogenated analog in healthy volunteers;Dorow,1983

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How to manage intolerance to dopamine agonist in patients with prolactinoma;Pituitary;2023-04

2. The Dopamine D2 Receptor Partial Agonist Antipsychotics, Aripiprazole, and Brexpiprazole;NeuroPsychopharmacotherapy;2022

3. The Dopamine D2 Receptor Partial Agonist Antipsychotics, Aripiprazole, and Brexpiprazole;NeuroPsychopharmacotherapy;2021

4. Fibrosis and carcinoid syndrome: from causation to future therapy;Nature Reviews Endocrinology;2009-05

5. Bromocriptine Reduces Augmented Thyrotropin Secretion in Obese Premenopausal Women;The Journal of Clinical Endocrinology & Metabolism;2009-04-01